The Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel is a specialized medication designed for topical application. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise dosing. The gel-like consistency ensures that the medication is applied directly to the affected area, providing targeted treatment. The combination of Ketamine HCL and Lidocaine HCL in the gel works synergistically to manage pain.
This transdermal gel is primarily indicated for the treatment of neuropathic pain, a type of chronic pain that can result from nerve damage due to various disease states, including diabetes, shingles, and spinal cord injury. Additionally, it may be used in the management of pain associated with fibromyalgia and complex regional pain syndrome (CRPS). The formulation is designed to minimize systemic absorption and provide relief directly at the site of pain, making it a valuable option for patients seeking localized pain management without the systemic side effects of oral medications.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel is a specialized medication compounded by our team at Bayview Pharmacy to provide targeted relief from pain. This semisolid formulation is designed to be administered through a pump mechanism, which ensures that patients can apply a consistent and precise dose of the medication directly to the area of discomfort. The gel base allows for the active ingredients, ketamine and lidocaine, to be absorbed through the skin, offering a non-invasive alternative to oral or injectable pain management options.
Ketamine, a medication primarily used for starting and maintaining anesthesia, has been found to have analgesic properties at lower doses. In this transdermal formulation, ketamine works by blocking NMDA receptors, which play a role in the transmission of pain signals in the nervous system. This can help reduce the sensation of pain, particularly in cases of neuropathic pain, which is often resistant to other treatments. Lidocaine, on the other hand, is a local anesthetic that provides temporary relief of pain by blocking the conduction of nerve impulses.
For patients, it is important to understand that this transdermal gel is to be used as directed by a healthcare professional, and the site of application should be clean and intact skin. Patients should be aware of potential side effects, such as local skin reactions or systemic effects, although the transdermal route of administration may reduce the likelihood of systemic side effects compared to oral or injectable forms of these medications. Prescribers should consider this formulation for patients who require localized pain management, or for those who have difficulty with traditional pain medication routes. Monitoring for efficacy and safety is recommended, as with all pain management strategies.
Our team at Bayview Pharmacy is committed to providing high-quality, customized medications to meet the unique needs of each patient. If you have any questions about the Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel, or if you would like to discuss its suitability for a particular patient or condition, please do not hesitate to reach out to us. We are here to support both patients and prescribers in achieving optimal therapeutic outcomes with our compounded medications.
The Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel is a compounded medication designed for topical application. It is important to consider potential drug interactions when using this formulation. Ketamine is an NMDA receptor antagonist and Lidocaine is a local anesthetic that blocks sodium channels. Both active ingredients are absorbed through the skin to provide localized relief.
When using this transdermal gel, patients should be aware of the potential for systemic absorption, which could lead to interactions with other medications. For example, CNS depressants, including alcohol, benzodiazepines, opioids, and barbiturates, may have additive effects when used concurrently with ketamine, potentially leading to increased sedation and respiratory depression. Similarly, other local anesthetics or medications that affect cardiac conduction, such as antiarrhythmic drugs, should be used with caution as there may be an increased risk of cardiac effects with lidocaine.
Patients taking anti-epileptic drugs, such as phenytoin or carbamazepine, should be monitored as these medications may alter the metabolism of lidocaine, potentially leading to increased plasma levels and toxicity. Additionally, certain antidepressants, such as MAO inhibitors or SSRIs, may interact with ketamine, increasing the risk of serotonin syndrome or hypertensive episodes. It is also important to consider the potential for drug interactions with any other topical medications applied to the same area due to the possibility of altered absorption or local skin reactions.
Patients with liver impairment should use this gel with caution, as both ketamine and lidocaine are metabolized by the liver, and impaired hepatic function could lead to increased systemic levels of the drugs. Furthermore, patients with cardiac conditions should be cautious, as lidocaine can have cardiac effects, particularly in the presence of other medications affecting cardiac function.
It is essential for patients to inform their healthcare providers of all medications they are currently taking, including over-the-counter drugs, supplements, and herbal products, to avoid potential interactions. Prescribers should thoroughly review the patient's medication history before recommending this transdermal gel to ensure safe and appropriate use.
This transdermal gel formulation is used for the management of localized pain, including neuropathic pain and may be beneficial in conditions such as postherpetic neuralgia or complex regional pain syndrome. The combination of ketamine and lidocaine works synergistically to provide analgesia by blocking pain signals at different points along the pain pathway. However, the efficacy and safety of this compounded formulation for treating specific disease states should be evaluated on a case-by-case basis, considering the patient's overall medical condition and concomitant medications.
If you have any questions or require further information regarding drug interactions or the appropriate use of Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
The Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel is a specialized medication designed for topical application. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise dosing. The gel is applied directly to the skin, where it is intended to provide localized relief from pain by delivering its active ingredients transdermally, or through the skin.
Ketamine, a medication primarily known for its anesthetic properties, functions in this formulation as an N-methyl-D-aspartate (NMDA) receptor antagonist. By blocking these receptors, ketamine can help reduce the sensation of pain, particularly neuropathic pain, which is pain caused by damage to the nervous system. This can be beneficial in treating conditions such as complex regional pain syndrome (CRPS), certain types of chronic pain, and neuropathies.
Lidocaine, on the other hand, is a local anesthetic and antiarrhythmic drug. It works by blocking sodium channels, which are necessary for the conduction of nerve impulses. When applied topically, lidocaine can help numb the targeted area, providing relief from pain by preventing the nerves from sending pain signals to the brain. This makes it useful for treating localized pain, including but not limited to, post-herpetic neuralgia, and other forms of localized pain syndromes.
The combination of ketamine and lidocaine in a transdermal gel allows for the synergistic effects of both medications. This means that the gel can provide both immediate numbing from the lidocaine and longer-term pain modulation from the ketamine. The transdermal delivery system is particularly advantageous for patients who may have difficulty with oral administration or those who require targeted pain relief without the systemic side effects that can occur with oral medications.
The gel should be applied as directed, typically to intact skin to avoid systemic absorption that could lead to unwanted side effects. The area of application should be clean and dry to ensure proper absorption of the active ingredients.
If you have any questions about the Ketamine HCL 5.75%/Lidocaine HCL 5% Transdermal Gel, or if you would like more information on how it might be beneficial for specific disease states, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and guidance needed to ensure appropriate treatment for our patients.
Aside from their primary indications for managing chronic pain and various neuropathic pain syndromes, the combination of Ketamine HCL and Lidocaine HCL in a transdermal gel form may offer additional therapeutic benefits for other conditions. For instance, the anti-inflammatory properties of Ketamine could potentially provide symptomatic relief in certain inflammatory skin conditions that have a neuropathic component. It's important to note that while Ketamine is also known for its use in psychiatric disorders such as depression, the topical application in this formulation is not intended for such purposes and its effectiveness for these indications via transdermal delivery has not been established.
In some cases, patients with complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy (RSD), may experience localized pain relief when applying the Ketamine/Lidocaine gel to the affected areas. Additionally, individuals enduring painful diabetic neuropathy might find transdermal delivery to be a suitable method to achieve pain control with potentially fewer systemic side effects. The transdermal route of administration presents an advantage in that it allows for a local effect of the drugs while minimizing systemic absorption, which may offer an improved side effect profile, an important consideration for patients who may not tolerate systemic medications well.
Moreover, research has suggested that topical Ketamine may have a role in the treatment of postherpetic neuralgia, the persistent pain following an outbreak of shingles. In scenarios where oral or systemic therapy produces inadequate relief or adverse reactions, a gel such as the Ketamine/Lidocaine formulation might be a viable alternative. Oncology patients with cutaneous metastatic lesions or very localized areas of pain may also benefit from the application of this transdermal gel in order to reduce discomfort without systemic opioid use; however, further exploration into the efficacy and safety of such applications is needed.
It is important to note that the off-label uses of the Ketamine/Lidocaine gel are based on its pharmacological properties and available clinical experience. These applications should be considered carefully and initiated under the supervision of a healthcare professional. Patients or prescribers interested in learning more about the potential other uses of Ketamine/Lidocaine 5.75%/5% Transdermal Gel are encouraged to reach out to us at Bayview Pharmacy for further information and to discuss individual patient needs and considerations.
This is a compounded medication that combines Ketamine HCL at a concentration of 5.75% and Lidocaine HCL at a concentration of 5% in a gel form for transdermal delivery. The transdermal route means it is intended to be applied to the skin, from where the active ingredients are absorbed into the body for localized or systemic effects.
The gel is dispensed through a pump mechanism which allows for easy and measured application. Apply a thin layer of the gel to the affected area of the skin as directed by your physician. After application, wash your hands properly unless your hands are the area being treated.
Ketamine HCL/Lidocaine HCL Transdermal Gel is commonly prescribed for various conditions such as chronic pain, nerve-related pain, or after recommendation by a healthcare provider for other off-label uses that they determine suitable.
The gel should only be applied to intact skin areas as recommended by your healthcare provider. Avoid applying it to broken skin, mucous membranes, or sensitive areas such as the eyes, nostrils, and mouth.
The frequency of application would depend on the instructions given by your physician based on your individual treatment plan. It is important to follow their guidance and not alter the dosing schedule without consulting them.
If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double doses to make up for a missed one.
As with any medication, side effects are possible. Common side effects might include skin irritation at the site of application or systemic effects related to ketamine or lidocaine usage. Always report any unusual symptoms or side effects to your healthcare provider.
Be sure to discuss with your healthcare provider about any other medications you are taking, as there may be potential interactions when combining this gel with other drugs, including topical preparations.
Store the medication at room temperature away from direct sunlight and heat. Do not freeze. Keep out of reach of children and pets.
Avoid using heating pads, electric blankets, saunas, or hot tubs immediately after applying the gel, as this may alter its absorption or increase the risk of side effects. Additionally, avoid covering the treated skin with occlusive dressings unless your healthcare provider advises you to do so.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding. Your provider will discuss with you the potential risks and benefits of its use.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)